Bruker Balance Sheet Health
Financial Health criteria checks 2/6
Bruker has a total shareholder equity of $1.8B and total debt of $2.1B, which brings its debt-to-equity ratio to 116.3%. Its total assets and total liabilities are $5.9B and $4.1B respectively. Bruker's EBIT is $428.2M making its interest coverage ratio 21.6. It has cash and short-term investments of $182.4M.
Key information
116.3%
Debt to equity ratio
US$2.12b
Debt
| Interest coverage ratio | 21.6x |
| Cash | US$182.40m |
| Equity | US$1.82b |
| Total liabilities | US$4.08b |
| Total assets | US$5.90b |
Recent financial health updates
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt
Sep 10
Is Bruker (NASDAQ:BRKR) Using Too Much Debt?
Oct 23Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet
Jul 11Recent updates
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt
Sep 10Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In
Aug 22Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?
Jul 22Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price
Jun 09Bruker: A Confusing Acquisition Spree
May 31Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations
May 09Bruker Corporation: An Aggressive Acquisition Strategy
Apr 24Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research
Apr 11Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)
Jan 22There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price
Jan 08Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?
Dec 26Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?
Nov 06Is Bruker (NASDAQ:BRKR) Using Too Much Debt?
Oct 23Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors
Sep 25Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?
Aug 09Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?
Jul 27Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet
Jul 11If EPS Growth Is Important To You, Bruker (NASDAQ:BRKR) Presents An Opportunity
Jun 26Financial Position Analysis
Short Term Liabilities: BRKR's short term assets ($2.2B) exceed its short term liabilities ($1.3B).
Long Term Liabilities: BRKR's short term assets ($2.2B) do not cover its long term liabilities ($2.8B).
Debt to Equity History and Analysis
Debt Level: BRKR's net debt to equity ratio (106.3%) is considered high.
Reducing Debt: BRKR's debt to equity ratio has increased from 55.3% to 116.3% over the past 5 years.
Debt Coverage: BRKR's debt is not well covered by operating cash flow (12.8%).
Interest Coverage: BRKR's interest payments on its debt are well covered by EBIT (21.6x coverage).